FORA Capital’s Meridian Bioscience Inc VIVO Stock Holding History

FORA Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,512	Closed	-$216K	–	748
2022 Q4	$216K	Buy	+6,512	New	+$210K	0.03%	428
2022 Q3	–	Sell	-15,478	Closed	-$471K	–	620
2022 Q2	$471K	Buy	+15,478	New	+$419K	0.09%	261
2020 Q4	–	Sell	-4,136	Closed	-$70K	–	1186
2020 Q3	$70K	Buy	+4,136	New	+$80.4K	0.05%	379
2020 Q2	–	Sell	-2,583	Closed	-$22K	–	1407
2020 Q1	$22K	Buy	+2,583	New	+$21.7K	﹤0.01%	943

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FORA Capital's VIVO Position: Q1 2023 in Review

FORA Capital sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,512 shares — an estimated $216K sold.

FORA Capital first reported a position in VIVO in Q1 2020 and held it in 4 quarters. The position peaked at $471K in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

FORA Capital reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
FORA Capital sold 6,512 Meridian Bioscience Inc shares in Q1 2023, an estimated $216K.
FORA Capital first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 4 quarters.
FORA Capital's Meridian Bioscience Inc position peaked at $471K in Q2 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on FORA Capital's 13F filing for Q1 2023, filed 12 May 2023.